Seems you have not registered as a member of localhost.saystem.shop!
You may have to register before you can download all our books and magazines, click the sign up button below to create a free account.
Acute Leukemias VII
The 7th volume of the book series Acute Leukemias provides new updates on the biology of acute leukemias and especially the underlying genetic and molecular events. High quality contributions are provided by leading scientists and clinicians making the book an excellent overview over most recent achievements which translate into new treatment strategies and hence an improved outlook for patients suffering from acute leukemias.
Acute Leukemias VIII
Since 1987 Acute Leukemias (AL) has regularly reported on the state of the art in the rapidly growing, successful and exciting field of biology and management of these diseases. In this volume large multicenter clinical trials again form the solid basis for the investigation of leukemic cell biology, the detection of biologic subgroups, their differential response to alternative treatment strategies and the further development of therapy. In particular, this volume addresses mechanisms of chromosomal translocations and transcription factors, risk-adapted treatment strategies, differentiation therapy, secondary AL, special aspects in older patients, and adoptive immunotherapy. Besides the antileukemic approaches, supportive treatment with new antimicrobial substances and growth factors is updated. As a forum of worldwide activities in the field of AL this volume contains both exhaustive overviews on major clinical issues and preliminary data and hypotheses not previously published.
Acute Leukemias IV
The rates of acute leukemia cure have gradually improved over the last decade. Clinical study results reflect the impact of chemotherapy intensity and duration, the role of prolonged maintenance, intensified consolidation or very early intensification. Further progress has also been achieved in bone marrow trans plantation, and recent prospective studies and meta-analyses have contributed comparisons of the high antileukemic efficacy of bone marrow transplantation to that of improved chemotherapy. This allows a more successful combining of the two forms of treatment. New prognostic factors have emerged from both cytogenetic and molecular genetic research. Thus, the Philadelphia chromosome tr...
Acute Leukemias
This is the third volume in this series on methods of treating acute leukemia. Multiple drug resistance is discussed, along with the use of human granulocyte-macrophage CSF, the role of stem cell factor, and basic aspects of cell biology and pharmakokinetics. There is also a comprehensive section dealing with relapse therapy and postremission therapy. The book thus provides the clinician with guidelines for use in everyday practice.
Acute Leukemias V
150 years after the first description of the clinical picture of "white blood" and the introduction of the term "leukemia" by R. Virchow it appears, that the leukemias, and the acute leukemias in particular, serve as an impressive example for the major improvements that have been achieved in the treatment but also in the understand ing of the biology of malignant dis orders. The international symposia "Acute Leukemia" which are held at Münster since 1986 have developed into an interna tional forum to review the current progress and the future perspectives of leukemia research and therapy at a high scientific and clinicallevel. Since the possibility for active participation in these symposia...
Acute Leukemias VI
For 10 years the book series Acute Leukemias has been providing updates on the rapid progress being made internationally concerning this group of diseases. The fifth volume mainly addressed experimental approaches, but the present issue presents both therapeutic and prognostic aspects of the most recent results from major multicenter clinical trials. Additional chapters report new trends in leukemia cell biology,the monitoring of minimal residual disease, and secondary leukemias, as well as new antileukemic drugs, antimicrobial strategies, and the use of cytokines. The combined efforts against acute leukemias described in this book explain the recent improvements in the outcome of patients suffering from acute leukemias.
Nuclear Structure of the Zirconium Region
Results important for the general understanding of nuclear structure have emerged from the study of the nuclei in the mass region around the neutron-deficient and neutron-rich Zirconium isotopes. This research report gives the proceedings of a workshop which brought together about 70 experts in the area. Review papers deal with the theoretical interpretation of the unusual properties of these medium-mass nuclei, using the mean field approach, a microscopic description, the interacting boson model and particle rotor calculations. Papers also discuss experimental procedures for studying nuclei far from stability and the possibility of complete spectroscopy. The reviews are supplemented by short contributions presenting very new results. Phenomena discussed include the interplay between subshell effects and the strong proton-neutron interaction in determining nuclear shape, the coexistence of different nuclear shape and the occurrence of fast beta decay.
Recent Advances in Cell Biology of Acute Leukemia
The development of new techniques such as immuno phenotyping, cytogenetic investigations and, more recently, molecular studies has considerably increased our diagnostic repertoire and broadened our ideas about the biology of acute leukemias. While immunophenotyping with mono clonal antibodies has yielded increased diagnostic precision and made it possible to develop a highly reproducible classification of acute leukemias based on cell-biological features, further insights have been gained into the patho genetic mechanisms involved in leukemogenesis by means of cytogenetic detection of acquired structural chromosomal abnormalities. Analysis of the leukemia-associated chromo somal breakpoints ...
The Slippery Slope of Healthcare
Dr. Steven Kussin, physician and a pioneer in the Shared Decision movement, takes readers through the steps of how to avoid the many pitfalls of unnecessary and sometimes even dangerous medical care. The American healthcare system is subsidized by its services to healthy people. The goal as it is for any business is to encourage people to become consumers by creating an emotionally-fueled demand for things that are suddenly and urgently needed. It’s hard to make healthy people well; it’s easy to make them sick. Under the goal to make you even healthier, the medical industry identifies and encourages investigations and preventive technologies for ‘problems’ unlikely to occur, unlikely...
